Trump announces trade deal with EU following months of negotiations
John E. Kao, the Chief Executive Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), has recently sold 90,000 shares of the company’s common stock. The shares were sold at a weighted-average price of $14.2256 per share, generating a total transaction value of approximately $1.28 million. The sale comes as the company’s stock has shown remarkable performance, with InvestingPro data showing a 125% return over the past year and a market capitalization of $2.77 billion.
Following this transaction, Kao retains ownership of 2,743,253 shares of Alignment Healthcare stock. The sale was conducted under a pre-established Rule 10b5-1 trading plan, which Kao adopted on March 14, 2024. The shares were sold in multiple transactions, with prices ranging from $14.06 to $14.375 per share. According to InvestingPro, the company maintains a GOOD overall financial health score, despite not being profitable in the last twelve months. Subscribers can access 8 additional ProTips and comprehensive financial analysis through the Pro Research Report.
The shares sold were held indirectly through the JEK Trust, for which Kao serves as trustee. After the sale, he continues to hold a significant stake in the company, with 2,183,100 shares remaining under indirect ownership. Based on InvestingPro’s Fair Value analysis, the stock is currently trading near its Fair Value, with analysts setting price targets ranging from $8 to $17 per share.
In other recent news, Alignment Healthcare has been the subject of positive analysis by Stifel analysts, who increased the company’s price target from $14.00 to $16.00, maintaining a Buy rating. The analysts highlighted the company’s strong Annual Enrollment Period (AEP) results and reiterated the guidance for 2024 and 2025. They also noted Alignment’s superior patient management through its technology-driven Medicare Advantage plan, setting it apart from competitors.
In addition to the favorable analyst review, Alignment Healthcare has reported a 35% year-on-year increase in health plan membership, which grew to approximately 209,900 members as of January 1. The company forecasts that this number will increase to between 225,000 and 231,000 by December 31, 2025. This projection aligns with the company’s ongoing growth strategy.
Stifel analysts further emphasized that Alignment’s strategic positioning and technological edge will continue to drive its success and market share acquisition in the coming years. The company’s positive outlook is also supported by anticipated changes in star rating mechanics in 2027, which are predicted to provide further growth opportunities. These are among the recent developments that indicate Alignment Healthcare’s promising prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.